Entasis Therapeutics to Host Expert Perspectives Webinar on Acinetobacter Infections

NEXT STORY
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
PREV STORY
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences to Present Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018

WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News

Kymera Therapeutics to Present New In Vivo Data Demonstrating the Broad Anti-Inflammatory Activity of its IRAK4 Degrader KT-474 at IMMUNOLOGY2021™ Annual Meeting

author_avatar
NASDAQ Market News

Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer     

BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc., (Nasdaq:ZIOP) today announced a ...

author_avatar
NASDAQ Market News